Dual EZH2 & Histone Deacetylase Inhibition Suppresses Cell Viability in Down Syndrome Myeloid Leukemia by Depleting EZH2

Blood Neoplasia · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles